Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.

Mt Sinai J Med

Medical Scientist Training Program, Mount Sinai School of Medicine, New York, NY 10029, USA.

Published: May 2002

The interferons are pleiotropic cytokines that are induced in response to virus infection and act in a paracrine fashion to elicit an antiviral state in nearby cells. Binding of interferons to their cell surface receptors induces a tyrosine kinase signaling cascade that leads to the activation of latent cytoplasmic signal transducer and activator of transcription (STAT) factors. Activated STATs then translocate into the nucleus and are targeted to conserved promoter-enhancer sites to induce the transcription of interferon-responsive genes that encode for proteins with potent antiviral, growth-inhibitory, antitumor, and immunomodulatory properties. Although the signaling and activation phase of the interferon response has been well characterized, several recent findings have further clarified the cellular events that immediately follow STAT activation, including the identification of the amino acid signals that regulate the subcellular distribution of interferon- signaling proteins. To achieve their full transcriptional capacity, members of the STAT family of transcription factors have been shown to require interactions with an assortment of nuclear transcriptional co-activator proteins. A number of the STAT co-activator protein partners have only been identified recently. Some of these interactions suggest cross-talk with other signaling pathways, thereby reaffirming the far-reaching, yet undiscovered, properties of interferons.

Download full-text PDF

Source

Publication Analysis

Top Keywords

signaling
5
mechanisms type
4
type interferon
4
interferon cell
4
cell signaling
4
signaling stat-mediated
4
stat-mediated transcriptional
4
transcriptional responses
4
responses interferons
4
interferons pleiotropic
4

Similar Publications

Dihydromyricetin (Dih), a naturally occurring flavonoid, has been identified to exert a protective effect against ischemia/reperfusion injury. However, the detailed mechanisms remain unclear. Here we investigated the biological role of Dih in preventing hypoxia/reoxygenation (H/R) injury in cardiomyocytes.

View Article and Find Full Text PDF

Adaptive immune resistance in cancer describes the various mechanisms by which tumors adapt to evade anti-tumor immune responses. IFN-γ induction of programmed death-ligand 1 (PD-L1) was the first defined and validated adaptive immune resistance mechanism. The endoplasmic reticulum (ER) is central to adaptive immune resistance as immune modulatory secreted and integral membrane proteins are dependent on ER.

View Article and Find Full Text PDF

Tumor necrosis factor receptor-associated factor 1 (TRAF1) is a crucial signaling adaptor involved in multiple cellular events. However, its role in regulating osteoclastogenesis and energy metabolism remains unclear. Here, we report that TRAF1 promotes osteoclastogenesis and oxidative phosphorylation (OXPHOS).

View Article and Find Full Text PDF

The developmental lipidome of Nippostrongylus brasiliensis.

Parasit Vectors

January 2025

Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, VIC, 3010, Australia.

Background: Nippostrongylus brasiliensis-a nematode of rodents-is commonly used as a model to study the immunobiology of parasitic nematodes. It is a member of the Strongylida-a large order of socioeconomically important parasitic nematodes of animals. Lipids are known to play essential roles in nematode biology, influencing cellular membranes, energy storage and/or signalling.

View Article and Find Full Text PDF

One hallmark of cancer is the upregulation and dependency on glucose metabolism to fuel macromolecule biosynthesis and rapid proliferation. Despite significant pre-clinical effort to exploit this pathway, additional mechanistic insights are necessary to prioritize the diversity of metabolic adaptations upon acute loss of glucose metabolism. Here, we investigated a potent small molecule inhibitor to Class I glucose transporters, KL-11743, using glycolytic leukemia cell lines and patient-based model systems.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!